DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global Transdermal Drug Delivery System Market Analysis 2016 - Forecast to 2022" report to their offering.
This report analyzes the global markets for "Transdermal Drug Delivery System". The market assessment is performed through standard and the tailored research methodology approach. The report also analyzes the market by discussing market dynamics such as drivers, constraints, opportunities, threats, challenges and other market trends.
The report contains up to date financial data derived from varied research sources to present unique and reliable analysis. Assessment of major trends with potential impact on the market during the next five years, including a deep dive analysis of market segmentation which comprises of sub markets, regional and country level analysis. The report provides a comprehensive outlook about the market share along with strategic recommendations based on the emerging segments.
Competitive landscaping provides the recent activities performed by the active players in the market. Activities such as product launch, agreements, joint ventures, partnerships, acquisitions and mergers, and other activities.
Key Topics Covered:
1 Introduction
2 Executive Summary
3 Market Analysis
4 Porters Five Force Analysis
5 Transdermal Drug Delivery System Market, by Technology
- Electric Current
- Electroporation
- Lontophoresis
- Mechanical Arrays
- Microporation
- Microneedles
- Radio Frequency
- Thermal
- Ultrasound
6 Transdermal Drug Delivery System Market, by Application
- Cardiovascular
- Central Nervous System
- Hormone
- Pain Management
- Other Applications
7 Geographical Segmentation
8 Vendor Landscaping
- Agreements, Partnerships, Collaborations and Joint Ventures
- Acquisitions & Mergers
- New Product Launch
- Expansions
- Other Key Strategies
9 Company Profiles
- 3M Company
- 4P Therapeutics, LLC
- Biogel Technology, Inc.
- Boehringer Ingelheim GmbH
- Echo Therapeutics, Inc
- Johnson & Johnson
- Mylan Pharmaceuticals, Inc
- Nemaura Pharma Ltd
- Novartis AG
- Noven Pharmaceuticals, Inc
- Skyepharma PLC
- Transdermal Corp
- Watson Pharmaceuticals, Inc
- Pantec Biosolutions AG
- Generex Biotechnology Corporation
10 Appendix
For more information about this report visit http://www.researchandmarkets.com/research/fkt64j/global
